John Allan, MD, reviews the diagnosis and treatment of a 67-year-old man with chronic lymphocytic leukemia while highlighting potential treatment options.
December 17th 2021
John Allan, MD, presents and reviews the case of a 67-year-old man with chronic lymphocytic leukemia.
A key opinion leader shares insight into testing and risk stratification for chronic lymphocytic leukemia.
John Allan, MD, highlights treatment options in the first-line setting for chronic lymphocytic leukemia.
December 20th 2021
A leukemia specialist details the Resonate-2 clinical trial studying BTK inhibitor ibrutinib.
John Allan, MD, compares the available approved BTK inhibitors for treating chronic lymphocytic leukemia.
An expert describes various treatment approaches for patients with high-risk chronic lymphocytic leukemia.
John Allan, MD, looks to the future of chronic lymphocytic leukemia treatments.